Saving people from melanoma
one patient at a time
About DigitalDerm
Headquartered in Columbia, S.C., DigitalDerm, Inc. was founded by leading melanoma expert James Grichnik, M.D., Ph.D. His vision was to adapt and upgrade previous total body photography techniques utilizing film and picture books to a computer based system. This would allow all end-users the ability to harness the speed and power of computer generated image display and manipulation. He also wanted it to be easy to use so it would encourage his patients to become an active contributor in the early melanoma detection process.
The company's first commercial offering, MoleMapCD® technology, was developed in conjunction with the Duke Comprehensive Cancer Center in Durham, N.C., where Dr. Grichnik was a researcher and clinician. In use for more than a decade at Duke and other medical facilities, MoleMapCD technology is the new standard of care for documenting the skin of patients at-risk of melanoma and enhancing the ability to identify melanoma in early, more treatable stages.
While MoleMapCD technology has a strong presence in the southeastern United States, DigitalDerm is launching MoleMapCD technology nationwide; exploring international introductions on a country-by-country basis; and developing new, functionality-enhanced releases of its technology.
Our Mission Statement
To develop and deliver to healthcare professionals the best service available and to make the life of those individuals who use our service as uncomplicated and user-friendly as possible.
A Message from our CEO
My vision for DigitalDerm, Inc., is to live out our company's mission statement:
To develop and deliver to healthcare professionals the best service available and to make the life of those individuals who use our service as uncomplicated and user-friendly as possible.
If we succeed, DigitalDerm will enable physicians to improve early detection of melanoma for at-risk patients through the adoption of the MoleMapCD System as a standard of care. As such, we will provide the most technologically advanced Total Body Photography imaging system available.
The DigitalDerm of the future will be larger and more complex than the company of today. However, we will strive to maintain our close relationships with the healthcare professionals and patients who use our services. As we grow, our commitment to quality of service will never waver.
The members of our DigitalDerm family are passionate about their work. They view this work as an opportunity to serve our clients and for personal development and fulfillment. They are unique individuals with dignity and intrinsic value, independent of the work they do. Their combined efforts will provide the unique service called MoleMapCD.
The quest is not for profits, but to provide the best quality MoleMapCD service. This objective will be accomplished because of the efforts and quality of our people. Their contributions will generate a high-quality service and corporate profits, while providing a beneficial service to patients who are at-risk for melanoma.
Martin Lefkowitz
CEO, DigitalDerm, Inc.
© DigitalDerm™, Inc. All rights reserved
MoleMapCD© is a registered trademark of DigitalDerm™, Inc.